Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

AACR: Drug Combo Shows Promise in Advanced Pancreatic Cancer

Loading...

Sign in or sign up now!
1,400
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Apr 18, 2008

http://www.medpagetoday.com
Daniel D. Von Hoff, M.D., of the Scottsdale Clinical Research Institute in Scottsdale, Ariz.

SAN DIEGO, April 17 -- More than 70% of patients with pancreatic cancer derived a clinical benefit when treated in a small, phase I trial with the combination of nanoparticle albumin bound paclitaxel (Abraxane) and gemcitabine (Gemzar), investigators reported here.

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (3)

Sign In or Sign Up now to post a comment!
  • @giacomoxyz12 Nope, not if you think of how rich the person or team that found a cure would be.

  • WE HAVE A LONG WAY TO GO BEFORE THEY FIND 'CURES' FOR ANY OF THESE DISEASES. WE GO INTO 'REMISSION' BUT, NO ONE GETS CURED. MAYBE THE BILLIONS RECEIVED MAKES IT WORTH 'NOT' FINDING A CURE?

  • Hi I saw your awesome video about pancreatic cancer. We are the Hirshberg Foundation for Cancer Research at UCLA medical center. Thanks so much for doing all you do to help find a cure.

    Please visit our foundation site at pancreatic "dot" org and we also do a huge run and walk for Cancer in Oct. every Halloween in So. Cal called the LA Cancer Challenge. You can read about it here LACancerChallenge "dot" com

    Looking forward to hearing from you and working together to beat this disease.

Loading...

0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more